Matches in Nanopublications for { ?s ?p "[When the optimized method was applied to the v-abl-transformed NIH 3T3-, the K 562 CML blast cell line and to nine cases of lowly malignant non-Hodgkin lymphomas it semiquantitatively discriminated the varying amounts of v-abl, bcr/c-abl and c-abl mRNA expressed within these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_assertion description "[When the optimized method was applied to the v-abl-transformed NIH 3T3-, the K 562 CML blast cell line and to nine cases of lowly malignant non-Hodgkin lymphomas it semiquantitatively discriminated the varying amounts of v-abl, bcr/c-abl and c-abl mRNA expressed within these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_provenance.
- NP265456.RASXV7gdxE9XQ0AQdyXj5uXbkbDNgAnfiEIIGDEqIICXM130_assertion description "[When the optimized method was applied to the v-abl-transformed NIH 3T3-, the K 562 CML blast cell line and to nine cases of lowly malignant non-Hodgkin lymphomas it semiquantitatively discriminated the varying amounts of v-abl, bcr/c-abl and c-abl mRNA expressed within these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265456.RASXV7gdxE9XQ0AQdyXj5uXbkbDNgAnfiEIIGDEqIICXM130_provenance.
- assertion description "[When the optimized method was applied to the v-abl-transformed NIH 3T3-, the K 562 CML blast cell line and to nine cases of lowly malignant non-Hodgkin lymphomas it semiquantitatively discriminated the varying amounts of v-abl, bcr/c-abl and c-abl mRNA expressed within these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_assertion description "[When the optimized method was applied to the v-abl-transformed NIH 3T3-, the K 562 CML blast cell line and to nine cases of lowly malignant non-Hodgkin lymphomas it semiquantitatively discriminated the varying amounts of v-abl, bcr/c-abl and c-abl mRNA expressed within these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_provenance.